Investors & Media

COMING SOON…

ABOUT US

Leveraging next-generation
antimicrobials to address significant
unmet medical needs in the treatment
of serious infectious diseases,
improving patient outcomes and
significantly reducing the urgent
threats posed by increasingly
antibiotic-resistant bacterial strains.

CONTACT US

Lakewood-Amedex, Inc.
3030 University Parkway
Sarasota, FL 34243
Main: (941) 225-2515

Privacy Policy

NEWSROOM

Lakewood-Amedex, Inc. to Present at 2018 BIO CEO & Investor Conference February 8, 2018
Lakewood-Amedex, Inc. Advances Bisphosphocin Nu-8 to IND-Enabling Studies to Treat Complicated Urinary Tract Infection December 4, 2017
Lakewood-Amedex Inc. Reports Positive Top-Line Data from Randomized Controlled Phase 1/2a Trial of Nu-3 Antimicrobial in Patients with Infected Diabetic Foot Ulcers September 27, 2017